Jackson targets the results to be obtained by the end of this year even though there is no guarantee for that. If successful, then that is a fast record in a vaccine development.
“That would be amazing. But if it was assumed everything went according to schedule,” said Dr. William Schaffner from Vanderbilt University Medical Center who was not involved in this study.
This news also affected the Moderna stock price which jumped nearly 15 percent in trading after the US market closed.
Fauci said, previous research only included young adults. The final test will involve those who are older as well as people with chronic health conditions and certain skin color populations.
Associated with the development of a similar vaccine, Fauci said that he supports it all. “We need lots of vaccines. We need vaccines for the world, not only for our country,” he said.